The Multi-Kinase Inhibitor Lucitanib Enhances the Antitumor Activity of Coinhibitory and Costimulatory Immune Pathway Modulators in Syngeneic Models.

Saved in:
Bibliographic Details
Title: The Multi-Kinase Inhibitor Lucitanib Enhances the Antitumor Activity of Coinhibitory and Costimulatory Immune Pathway Modulators in Syngeneic Models.
Authors: Robillard L; Departments of Translational Medicine., Liao M; Clinical Pharmacology, Clovis Oncology Inc., Boulder, CO., Nguyen M; Departments of Translational Medicine., Harding TC; Departments of Translational Medicine., Simmons AD; Departments of Translational Medicine., Dusek RL; Departments of Translational Medicine.
Source: Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2022 Oct 01; Vol. 45 (8), pp. 335-348. Date of Electronic Publication: 2022 Jul 06.
Publication Type: Journal Article
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9706083 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-4513 (Electronic) Linking ISSN: 15249557 NLM ISO Abbreviation: J Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1537-4513
DOI:10.1097/CJI.0000000000000427